Publications by authors named "J V Borley"
Little is known regarding uptake of epithelial ovarian cancer (EOC) treatments or patient burden in UK real-world practice. Cross-sectional surveys of patients with advanced EOC and healthcare professionals (HCPs). 101 HCPs and 142 patients participated.
View Article and Find Full Text PDFBiomarkers may offer unforeseen insights into clinical diagnosis, as well as the likely course and outcome of a condition. In this paper, the focus is on the use of biological molecules found in body fluids or tissues for diagnosis and prediction of outcome in ovarian cancer patients. In cancer care, biomarkers are being used to develop personalised treatment plans for patients based on the unique characteristics of their tumour.
View Article and Find Full Text PDFArticle Synopsis
- The study evaluates the effectiveness and safety of laparoscopic uterine artery occlusion (LUAO) during laparoscopic myomectomy (LM), focusing on morbidity and leiomyoma recurrence rates.
- A systematic review of data from multiple databases identified twelve relevant studies, indicating LUAO-LM shows reduced intraoperative blood loss and lower postoperative complications without any LUAO-related complications reported.
- The results suggest that LUAO-LM improves surgical outcomes for women with symptomatic leiomyomas, although caution is advised due to potential biases in the studies analyzed.
Background: Survival benefit from surgical debulking of ovarian cancer (OC) is well established, but some women, despite total macroscopic clearance of disease, still have poor prognosis. We aimed to identify biomarkers to predict benefit from conventional surgery.
Methods: Clinical data from women debulked for high-stage OC were analysed (Hammersmith Hospital, London, UK; 2001-2014).